Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 3 (2006), Issue 11 (November)

1. Sustained attention and executive functions in euthymic young people with bipolar disorder.
   Br J Psychiatry, 189: 453-8. [Abstract] [Full-text]
2. Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials.
   Curr Med Res Opin, 22(11): 2233-42. [Abstract] [Full-text]
3. Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children.
   Biol Psychiatry, 60(10): 1106-10. [Abstract] [Full-text]
4. The P11, tPA/plasminogen system and brain-derived neurotrophic factor: Implications for the pathogenesis of major depression and the therapeutic mechanism of antidepressants.
   Med Hypotheses, 68(1): 180-3. [Abstract] [Full-text]
5. Familial resemblance for executive functions in families of schizophrenic and bipolar patients.
   Psychiatry Res, 144(2): 131-8. [Abstract] [Full-text]
6. Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples.
   Psychiatry Res, 144(2): 153-66. [Abstract] [Full-text]
7. Chromosomal fragile site expression in Turkish psychiatric patients.
   Psychiatry Res, 144(2): 197-203. [Abstract] [Full-text]
8. Factors associated with frequent admissions to an acute geriatric psychiatric inpatient unit.
   J Geriatr Psychiatry Neurol, 19(4): 226-30. [Abstract] [Full-text]
9. Self-reported thyroid disease and mental disorder prevalence in the general population.
   Gen Hosp Psychiatry, 28(6): 503-8. [Abstract] [Full-text]
10. Clinical outcome in bipolar disorder in a community-based follow-up study in Butajira, Ethiopia.
    Acta Psychiatr Scand, 114(6): 426-34. [Abstract] [Full-text]
11. Is FKBP5 a genetic marker of affective psychosis? A case control study and analysis of disease related traits.
    BMC Psychiatry, 6: 52. [Abstract] [Full-text]
12. Psychopharmacology of pediatric bipolar disorder: a review.
    Psychopharmacology (Berl). [Abstract] [Full-text]
13. The association between course of illness and subsequent morbidity in bipolar I disorder.
    J Psychiatr Res, 41(1): 80-9. [Abstract] [Full-text]
14. Bipolar and schizophrenic patients differ in patterns of visual motion discrimination.
    Schizophr Res, 88(1): 208-16. [Abstract] [Full-text]
15. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: Preliminary results from a clinical population.
    Schizophr Res, 88(1): 227-31. [Abstract] [Full-text]
16. Is hippocampal atrophy a future drug target?
    Med Hypotheses. [Abstract] [Full-text]
17. Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder.
    Neuropsychopharmacology, 31(12): 2739-47. [Abstract] [Full-text]
18. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    J Clin Psychopharmacol, 26(6): 600-9. [Abstract] [Full-text]
19. Manic behaviour induced by deep-brain stimulation in Parkinson's disease: evidence of substantia nigra implication?
    J Neurol Neurosurg Psychiatry, 77(12): 1363-6. [Abstract] [Full-text]
20. Assessment of quality of life with the WHOQOL-BREF in a group of Turkish psychiatric patients compared with diabetic and healthy subjects.
    Psychiatry Clin Neurosci, 60(6): 693-9. [Abstract] [Full-text]
21. Lack of association of an insertion/deletion polymorphism in the G protein-coupled receptor 50 with bipolar disorder in a Northern Swedish population.
    Psychiatr Genet, 16(6): 235-6. [Abstract] [Full-text]
22. No association between genetic variants at the ASCT1 gene and schizophrenia or bipolar disorder in a German sample.
    Psychiatr Genet, 16(6): 233-4. [Abstract] [Full-text]
23. Bipolar 1 disorder is not associated with the RGS4, PRODH, COMT and GRK3 genes.
    Psychiatr Genet, 16(6): 229-30. [Abstract] [Full-text]
24. Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms.
    Psychiatry Res, 145(2): 215-23. [Abstract] [Full-text]
25. An organic selenium compound attenuates apomorphine-induced stereotypy in mice.
    Neurosci Lett, 410(3): 198-202. [Abstract] [Full-text]
26. Olanzapine attenuates brain damage after focal cerebral ischemia in vivo.
    Brain Res Bull, 71(1): 296-300. [Abstract] [Full-text]
27. Psychopathology in the young offspring of parents with bipolar disorder: a controlled pilot study.
    Psychiatry Res, 145(2): 155-67. [Abstract] [Full-text]
28. Co-occurring Alcohol Use and Mental Disorders.
    J Clin Psychopharmacol, 26: S30-6. [Abstract] [Full-text]
29. Differential effect of serum from bipolar versus schizophrenic patients on spontaneous acetylcholine release at mammalian neuromuscular junction.
    Clin Neurophysiol, 117(12): 2645-52. [Abstract] [Full-text]
30. Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A(2) in rat frontal cortex.
    Pharmacogenomics J, 6(6): 413-20. [Abstract] [Full-text]
31. Abnormal Ca2+ dynamics in transgenic mice with neuron-specific mitochondrial DNA defects.
    J Neurosci, 26(47): 12314-24. [Abstract] [Full-text]
32. Effects of lithium carbonate on rat seminiferous tubules: an ultrastructural study.
    Int J Androl, 29(6): 576-82. [Abstract] [Full-text]
33. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
    Pharmacopsychiatry, 39(6): 233-4. [Abstract] [Full-text]
34. Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine.
    Eur Neuropsychopharmacol, 17(2): 102-7. [Abstract] [Full-text]
35. Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients.
    Eur Neuropsychopharmacol, 17(3): 194-8. [Abstract] [Full-text]
36. Evidence of linkage and association on 18p11.2 for psychosis.
    Am J Med Genet B Neuropsychiatr Genet, 141(8): 868-73. [Abstract] [Full-text]
37. Bipolar I and bipolar II disorder: cognition and emotion processing.
    Psychol Med, 36(12): 1799-809. [Abstract] [Full-text]
38. A genome-wide linkage search for bipolar disorder susceptibility loci in a large and complex pedigree from the eastern part of Cuba.
    Am J Med Genet B Neuropsychiatr Genet, 141(8): 833-43. [Abstract] [Full-text]
39. Daytime cortisol and stress reactivity in the offspring of parents with bipolar disorder.
    Psychoneuroendocrinology, 31(10): 1164-80. [Abstract] [Full-text]
40. Validation of the Portuguese version of the Lithium Attitudes Questionnaire (LAQ) in bipolar patients treated with lithium: cross-over study.
    Clin Pract Epidemol Ment Health, 2: 32. [Abstract] [Full-text]
41. Lymphocyte G-protein receptor kinase (GRK)3 mRNA levels in bipolar disorder.
    Int J Neuropsychopharmacol, 9(6): 761-6. [Abstract] [Full-text]
42. Costs of community-based public mental health services for older adults: variations related to age and diagnosis.
    Int J Geriatr Psychiatry, 21(12): 1121-6. [Abstract] [Full-text]
43. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Depress Anxiety. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.